Viewing nowLosartan Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.

MFDS item code 200600087 · Notified 2006.02.02 · Insurance code 655600430
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
This medication is primarily used for the treatment of hypertension. It also helps prevent or treat renal complications in patients with type 2 diabetes accompanied by hypertension. Therefore, it is used to control blood pressure and protect the kidneys related to hypertension.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be given orally in two divided doses daily, or the dose may be increased to 100 mg once daily if needed. If blood pressure is not controlled with this medicine alone, it may be used in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when coadministered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Older adults: No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced intravascular volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be taken by individuals with hypersensitivity to it, pregnant women, women who may become pregnant, patients with severe liver dysfunction, or patients with certain hereditary diseases. Additionally, elderly patients, patients with compromised kidney function, and patients with hyperkalemia should be monitored closely while taking this medication, and it is not recommended to use it in conjunction with other RAAS acting drugs. During use, side effects such as dizziness, muscle cramps, cough, and dyspepsia may occur; if symptoms are severe, consult a physician. This medication can affect liver and kidney function, so patients with liver or kidney diseases may require dose adjustments, and if blood pressure drops too low or symptoms of renal failure appear, notify the medical personnel immediately. Due to the risk of elevated serum potassium levels, it is advisable to avoid taking potassium supplements or medications containing potassium together with this medication. Regular monitoring of blood pressure and blood tests to check kidney function and electrolyte status is necessary during use. This medication is not recommended for breastfeeding women, nor should it be used in children, especially in those under the age of 6 or those with severely impaired kidney function. In case of an overdose, hypotension and bradycardia may occur, and immediate appropriate treatment at a medical institution is necessary; this medication is not removed by hemodialysis. Caution is advised while driving or operating machinery as dizziness may occur, and the medication should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer period.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.